EVE Health Group Limited / Fundamentals
Income statement
- Net revenue
€2.29M - Cost of goods sold
€2.03M - Gross profit
€251.82K - SG&A expenses
€2.01M - R&D expenses
€0.00 - EBITDA
-€1.71M - D&A
€70.59K - EBIT
-€1.74M - Interest expenses
€45.14K - EBT
-€1.78M - Tax expenses
€1.14M - Net income
-€2.99M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€421.00K - Changes in working capital
€0.00 - Operating cash flow
-€1.45M - Capex
-€1.68 - Other investing cash flow
€1.07M - Net investing cash flow
€1.60M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
-€192.26K - Net financing cash flow
-€192.26K - Foreign exchange effects
-€107.62K - Net change in cash
€24.36K - Cash at end of period
€215.22K - Free cash flow
-€1.45M
Balance sheet
- Cash and cash equivalents
€215.22K - Cash and short-term investments
€215.22K - Total receivables
€3.06K - Inventory
€111.67K - Other current assets
€176.85K - Total current assets
€506.80K - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€0.00 - Total assets
€506.80K - Accounts payable
€188.76K - Short-term debt
€84.82K - Other current liabilities
€0.00 - Total current liabilities
€273.58K - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€273.58K - Common stock
€21.32M - Retained earnings
-€19.80M - Other equity
-€1.28M - Total equity
€233.21K - Total liabilities and shareholders' equity
€506.80K
Company information
- Market capitalization
€3.98M - Employees
3 - Enterprise Value
€4.38M
Company ratios
- Gross margin
-
11.0% Much better than peer group: -36.7% - EBITDA margin
-
-74.8% Much better than peer group: -2,286.4% - EBIT margin
-
-76.2% Much better than peer group: -1,600.0% - EBT margin
-
-77.7% Much better than peer group: -2,989.5% - Net margin
-
-130.9% Much better than peer group: -2,361.0% - ROE
-
-1,282.9% Much worse than peer group: -103.4% - ROA
-
-590.4% Much better than peer group: -1,085.1% - Asset turnover
-
451.0% Much better than peer group: 51.3% - FCF margin
-
-63.3% Much better than peer group: -1,748.4% - FCF yield
-36.3% - Efficiency ratio
174.8% - Net sales per employee
-
€761.95K - Net income per employee
-
-€997.30K